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ABSTRACT  Addition  of polypeptide growth factors to cultured  cells  results in a rapid stimulation  of 
Na+/H ÷ exchange, which  leads to cytoplasmic  alkalinization.  We  studied  the effects  of the  potent 
tumor  promoter  phorbol  12-myristate  13-acetate  (PMA)  on  the  Na+/H ÷ exchange  system  of A431 
cells.  Stimulation  of  Na+/H + exchange  by  epidermal  growth  factor  (EGF) and  serum  as well  as  by 
vanadate  ions is strongly  inhibited  after treatment  of cells with  nanomolar  concentrations  of  PMA. 
Phorbol esters that have no activity as tumor promotors also do not modulate the activation  of Na+/ 
H ÷ exchange.  By contrast, the stimulation  of Na+/H ÷ exchange that is produced  upon exposure of 
cells to hypertonic solution is only slightly inhibited by PMA treatment, indicating that PMA treatment 
does not directly  block the activity  of the  Na+/H + antiporter.  Furthermore,  incubation  of cells with 
PMA  causes a  weak  stimulation  of  Na+/H +  exchange,  although  this  effect  is  mostly  observed  at 
relatively  high  PMA concentrations and appears to require external Ca  2+. The inhibition  BY PMA of 
EGF-promoted  Na+/H + exchange is not due to inhibition  of EGF-binding to the EGF receptor. Since 
PMA activates  protein  kinase  C,  our  observations  are consistent  with  the  hypothesis that  protein 
kinase C functions to attenuate the stimulation  of Na+/H + exchange by polypeptide growth factors. 
Stimulation of an amiloride-sensitive Na  ÷ uptake is a  ubiq- 
uitous  consequence  of the  addition  of polypeptide growth 
factors  (mitogens)  to  cells.  This  increased  Na  ÷  uptake  is 
primarily due to activation ofNa+/H  + exchange (1-7). Recent 
studies  have demonstrated that  stimulation  of Na+/H  + ex- 
change by mitogens leads to an increase in cytoplasmic pH 
(8-11).  This  cytoplasmic alkalinization  is  likely to  have  a 
permissive role in the mitogenic response of cells to growth 
factors (12). 
Phorbol diester derivatives that are potent tumor promoters 
in the mouse skin model system have recently been found to 
exert a wide variety of biological responses in cells.  Phorbol 
12-myristate 13-acetate (PMA),~ the most potent compound 
from this  series,  is  mitogenic  for  a  number  of fibroblasts, 
acting  synergistically with  growth  factors (see  reference  13 
and  references therein),  while  in  other  cells  PMA  induces 
differentiation (for a  recent review,  see  reference  14). Bio- 
chemical investigations suggest that the Ca  2+ and phospho- 
lipid-dependent protein kinase (protein kinase C) is the major 
i Abbreviations used in this paper.  EGF,  epidermal growth factor; 
PMA, phorbol 12-myristate 13-acetate. 
target for PMA  action.  PMA  is  a  potent  protein  kinase C 
activator  in  vitro,  apparently  substituting  for  the  natural 
activator diacylglycerol, which  is produced  upon  hormonal 
stimulation of phosphatidylinositol turnover (reviewed in ref- 
erence 15). Binding studies ( 16-18) suggest that protein kinase 
C is also the cellular phorbol diester "receptor." One of the 
substrates  of activated  protein  kinase  C  is  the  epidermal 
growth  factor (EGF)  receptor.  Activated  protein  kinase  C 
catalyzes the phosphorylation of serine and threonine residues 
on the EGF receptor, resulting in a decrease in the tyrosine- 
specific protein kinase activity of this mitogen receptor (19, 
20). These observations suggest a regulatory interrelationship 
between protein kinase C and growth factor receptors. That 
such regulation may indeed operate in cells is suggested by 
the findings that addition  of EGF to A431  cells (21,  22) or 
platelet-derived  growth  factor to  3T3  cells  (23)  stimulates 
phosphatidylinositol turnover which is likely to result in pro- 
tein kinase C activation. 
In this study, we investigated the functional consequences 
of treatment of cells with PMA upon an early growth factor- 
mediated  response,  that  is  the  stimulation  of Na*/H  ÷ ex- 
change. We show that PMA treatment strongly inhibits this 
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activation of protein kinase C. 
MATERIALS  AND  METHODS 
Phorbol derivatives were purchased from Sigma Chemical Co. (St. Louis, MO) 
and 22Na* was from New England  Nuclear  (Boston,  MA).  Sources of other 
reagent and cell culture  methods have been described (10). Amiloride and 5- 
alkylamino  substituted  amiloride  analogs were provided by Dr. E. J. Cragoe, 
Jr. (Merck Sharp and Dohme Research Laboratories). [nSI]EGF was prepared 
as described by Lieberman et al. (24). 
Physiological Salt Solution  (Solution A):  120 mM NaCI, 5.4 
mM KCI, 1.8 mM CaC12, 1 mM MgSO4, 1 mM Pi, 25 mM glucose, 25 ram 
morpholinopropane sulfonic acid-NaOH, pH 6.8 or 7.2. 
Fluorimetric Measurements  of Intracellular pH:  A431 cells 
grown on glass slides that have just reached confluency were loaded with the 
fluorescent pH indicator  4',5'-dimethylfluorescein  coupled to dextran  as pre- 
viously described (10), except that the concentration  of  sucrose in the hypertonic 
loading  solution  was increased  to  1.0  M.  This modification  of the loading 
solution  was found to increase the amount of dye in the cell cytoplasm three 
to five times,  which  allowed  a  reduction  of the  4',5'-dimethylfluorescein- 
dextran  concentration  in the solution to 10%. For measurement of phi, cells 
were incubated in solution A, pH 6.8, at 37°C in a thermostated  fluorimeter as 
described  previously  (10). Calibration  of pHi vs. fluorescence was obtained 
following the equilibration  of pHi with  extracellular  pH in the presence  of 
ouabain (10). 
RESULTS 
Effect of PMA on the Intracellular pH 
Addition of PMA to A431  cells (Fig.  1) results in a small 
increase in pHi following a brief lag period. Relatively high 
PMA concentrations (~0.1  uM) are required to rapidly pro- 
mote pHi elevation, while 10 nM PMA has little effect during 
the first 15 min (Fig.  1) or even after 1 h (ApHi -0.05, data 
not shown). Similarly, Burns and Rozengurt (25) have shown 
that 100 nM phorbol 12,13-dibutyrate induces a pHi increase 
of 0.08 U in Swiss 3T3 cells, pHi elevation by PMA in A431 
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FIGURE  I  Effect of PMA on pHi in A431 cells, pHi was monitored 
as described in Materials and Methods. In the second experiment 
the  cells  were  preincubated for  10  min  with  20  /~M  5-N(ethyl 
isopropyl)amiloride  (A7) (27) before addition of PMA. 
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FIGURE 2  Effect of PMA treatment on mitogen-stimulated 22Na+ 
uptake. Cells in 35-mm dishes (1.2 x  106 cells/dish) were preincu- 
bated for 1 h in solution A, pH 7.2 in the presence or absence of 
phorbol diesters. 22Na+  uptake was subsequently  assayed by switch- 
ing the cells to 1 ml solution A, pH 7.2, containing 0.5 mM ouabain 
and 2.5 x  106 cpmlml [22Na+]  with or without EGF (300 ng/ml) or 
dialyzed FCS (5% vol/vol). Hatched bars indicate the addition of 50 
#M 5-N,N-dimethylamiloride.  Mitogens increase the rate of amilor- 
ide-sensitive  Na  ÷ uptake,  i.e., the difference in the rate shown by 
the open bars and cross-hatched bars. After a 12-min uptake period 
at 37°C cellular 22Na+ content was assayed as described (7). The 
same results, as shown in this figure, have been obtained in at least 
three independent experiments. Note that while PMA blocks the 
mitogen-induced amiloride-sensitive Na  ÷ uptake,  phorbol esters 
which are inactive as tumor promoters and do not bind to protein 
kinase C,  i.e., 4a-phorbol 12,13-didecanoate and phorbol 12,13- 
diacetate, do not modulate the mitogen-induced Na  + uptake. 
cells depends on the presence of Na  t  in the incubation solu- 
tion (not  shown) and  is eliminated in  the  presence of the 
potent Na÷/H  + exchange inhibitor 5-N-(ethyl isopropyl)-ami- 
loride (AT) (see references 12, 26, 27). These findings suggest 
that  PMA  promotes  cytoplasmic alkalinization  by  weakly 
stimulating Nat/H  + exchange activity. Unlike PMA, the in- 
active phorbol  analogues  phorbol  12,13-diacetate and  4a- 
phorbol  12,13-didecanoate did not cause cytoplasmic alkal- 
inization. Thus, the capacity of phorbol diesters to cause pHi 
elevation shows similar structural requirements as those pre- 
viously reported for the activity of these compounds as tumor 
promoters (for a review, see reference 28) and as activators of 
protein kinase C (29). 
Previous studies (7,  10) have shown that the stimulation of 
Nat/H  t  exchange by mitogens is  independent  of external 
calcium.  By contrast, pHi  elevation by PMA  is essentially 
abolished in Ca2+-free solution (Fig.  1). 
Effect of PMA on the Stimulation of Na+/H  + 
Exchange by Mitogens 
We have reported previously that EGF and serum stimulate 
Na+/H  ÷ exchange in A431  cells resulting in the stimulation 
of an amiloride-sensitive 22Nat uptake and pHi elevation (7, 
10). In  Fig.  2,  we  tested the effect of phorbol diesters on 
mitogen-stimulated 22Nat uptake.  It can be seen that treat- 
ment of cells  with  10 nM PMA  strongly inhibits EGF and 
serum-stimulated 22Na+ uptake while only slightly  affecting 
the basal  Na  ÷ uptake determined in the presence of 5-N,N- 
dimethylamiloride. The inactivate phorbol diesters phorbol 
12,13-diacetate  and 4a-phorbol  12,13-didecanoate at a con- 
centration 10 times higher than that of PMA have no effect 
on 22Nat uptake either in the presence or absence of  mitogens. 
In agreement with the 22Na+ uptake data, treatment of cells 
with  10  nM  PMA  for  1 h,  strongly inhibits pHi elevation 
induced  by  EGF  and  serum  (Fig.  3,  A  and  B)  while  the 
inactive analogues phorbol  12,13-diacetate and  4a-phorbol 
12,13-didecanoate have no effect (not shown). We previously 
found (30) that addition of vanadate to A431 cells also results 
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FIGURE  3  Effect of PMA treatment on pHi elevation by various activators  of Na+/H * exchange. (A-D)  Cells were preincubated 
for 1 h with or without 10 nM PMA, followed by the addition of Na+/H ÷ exchange activators  as indicated. Baselines indicate the 
fact that phi increases by ~0.05  U during the PMA treatment (see Fig. 1). (E) Cells were preincubated for 15  min in Ca2+-free 
solution A containing 0.2 mM EGTA in the presence or absence of 100 nM PMA before the addition of EGF and serum. 
in a stimulation ofNa*/H  ÷ exchange and cytoplasmic alkalin- 
ization.  As shown in Fig.  3 C, pHi elevation by vanadate is 
inhibited by PMA treatment by -75 %. Na+/H  + exchange can 
also  be  activated  in  A431  cells  by  exposing  the  cells  to 
hypertonic medium (D. Cassel and B. Whiteley, unpublished 
observations). The data in Fig.  3 D  show that the activation 
of Na*/H  + exchange upon exposure to hypertonic medium is 
only slightly  inhibited  by PMA.  Activation  of Na+/H  ÷ ex- 
change by loading cells with Na  ÷ (7,  10) is also not affected 
by PMA (data not shown).  This indicates that treatment of 
cells with PMA does not impair the functionality of the Na÷/ 
H ÷ antiporter,  but  rather impairs the  mechanism by which 
growth factors and vanadate activate this antiporter. 
Since we found that PMA fails to elevate pHi in Ca2÷-free 
solution (Fig.  1), it was interesting to determine whether PMA 
treatment can inhibit mitogen-dependent pHi elevation under 
these conditions.  The results (Fig.  3 E) show that treatment 
of cells with PMA in Ca2+-free solution results in an effective 
inhibition  of mitogen-induced pHi elevation similar to that 
observed in normal physiological solution containing 1.8 mM 
Ca  2+. Note that the experiment in  Fig.  3E was carried out 
with a  rather high PMA concentration of 100 mM to mini- 
mize the time of exposure of cells to Ca2*-free medium (the 
inverse relationship between PMA concentration and the time 
required for inhibition  of Na+/H  ÷ exchange is described be- 
low). 
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FIGURE 4  Kinetics of the inhibition by PMA of mitogen-promoted 
phi  elevation, (A) Time  course.  Following preincubation with  10 
nM  PMA for the  indicated  periods,  EGF  (100  ng/ml)  +  fetal  calf 
serum (1% vol/vol) were added and the increase in phi was deter- 
mined. Zero time point indicates phi elevation in control system 
that did  not receive PMA.  (B)  Dose  response.  Cells  were treated 
with the indicated PMA concentrations for 1 h. Subsequently, EGF 
(100 ng/ml) +  fetal calf serum (1%) were added and the increase in 
phi was determined. 
Kinetics of PMA Effect on Mitogen-induced pHi 
Elevation 
As shown in  Fig.  4A, inhibition  of mitogen-induced pHi 
elevation, assayed in this experiment using the potent com- 
bination of EGF and serum, depends on preincubation of the 
cells with PMA. While treatment of cells with  10 nM PMA 
for 2 min has little effect, treatment for longer periods leads 
to progressive decrease in mitogen-dependent pHi elevation. "_o 
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FIGURE  5  ['251]EGF-bind- 
ing  in  control  and  PMA- 
treated A431 cells. Cells in 
35-mm  dishes  (1.2  x  106 
cells/dish)  were  preincu- 
bated for  1  h  at  37°C  in 
solution A, pH 7.2, with or 
without 10 nM  PMA. Sub- 
sequently,  the  medium 
was removed and replaced 
with 0.9  ml cold  solution 
A,  pH  7.2,  containing 0.2  ng/ml bovine serum album in and the 
indicated [t2Sl]FGF concentrations. After incubation at 0°C for 15 
min, the cells were washed three times with cold buffer. [t251]EGF 
was extracted with 0.3 M acetic acid and radioactivity was assayed 
in a "/' counter. Nonspecific binding at the lower [~2Sl]EGF concen- 
trations, determined by the addition of 250-fold excess of unlabeled 
FGF, was only 2-4% of the total binding and was not significantly 
affected by PMA treatment. 
The time required for inhibition of the mitogen-induced pHi 
elevation decreases with  increasing the  PMA  concentration 
(data not shown). For example, at  100 mM PMA, full inhi- 
bition  is  observed  after  15  min  incubation,  while  1  h  is 
required  at  10  mM  PMA,  as  shown  in  Fig.  4A.  A  dose 
response for the inhibition of mitogen-dependent pHi eleva- 
tion upon treatment of cells with PMA for  1 h  is shown in 
Fig.  4B. The effect of PMA is half maximal at  1-2 nM and 
becomes maximal at -10 nM. Similar PMA concentrations 
were reported to be required  for inhibition  of [3H]phorbol 
12,13-dibutyrate binding to the phorbol diester receptor (16, 
31) and for the activation of protein kinase C by PMA (29). 
Effect of PMA on [1251]EGF Binding 
To  investigate whether  the  inhibition  by PMA  of EGF- 
stimulated  Na+/H  ÷ exchange  is  due  to  a  decrease  in  the 
number of EGF receptors in the cell membrane, we tested the 
effect of PMA treatment on [J25I]EGF binding to A431  cells. 
Cells were preincubated for  I  h  at  37"C  in  the presence or 
absence of 10  nM  PMA,  and  [~25I]EGF binding was subse- 
quently assayed at 0*C to eliminate ligand internalization and 
degradation.  As shown  in  Fig.  5,  PMA  treatment causes a 
uniform  decrease  in  [~25I]EGF binding  by  -35%  over the 
entire range of [~25I]EGF concentrations tested (4-200 nM). 
A similar decrease in [~2SI]EGF  binding was also observed at 
still lower EGF concentrations of 10-1,000 pM (not shown). 
Thus, unlike in some other cells (32), PMA treatment of A431 
cells appears to reduce the number of EGF receptors, rather 
than reduce receptor affinity. Smith et al. (22) have reported 
that PMA treatment has no effect on the binding of [~2SI]EGF 
(1  ng/ml) at  37°C  to A431  cells.  We have confirmed these 
results but found that PMA treatment does inhibit [~2Sl]EGF 
binding at 37"C by 20-25%  when higher [~2SI]EGF concen- 
trations (25-200 nM) are employed (data not shown). In any 
event, the observed decrease in the number of EGF receptors 
as measured either at 0*C or at 37°C cannot account for the 
complete inhibition  by PMA of the  stimulation of Na+/H  ÷ 
exchange by EGF,  suggesting that  this inhibition  is  largely 
due  to  some additional  PMA-induced  modification  of the 
EGF receptor or other cellular targets. 
DISCUSSION 
We show in this study that treatment of A431  cells with PMA 
inhibits  the  stimulation  of Na+/H  + exchange  by mitogens. 
The dose response for PMA (IC5o =  1-2 nM) and the specific 
structural requirements of phorbol esters mediating this effect 
are consistent with the hypothesis that PMA inhibits mitogen- 
promoted Na+/H  + exchange by activating the phospholipid 
and CaE+-dependent  protein kinase (protein kinase C). Recent 
work has demonstrated that protein kinase C phosphorylates 
serine and threonine residues on the EGF receptor in A431 
membrane preparations and that this modification results in 
a decrease in receptor autophosphorylation on tyrosine resi- 
dues (19, 20). A similar modification of the EGF receptor was 
detected  upon  incubation  of intact  A431  cells with  PMA, 
which also resulted in a decrease in EGF-promoted phospho- 
rylation of tyrosine residues  on  cellular proteins (19).  This 
suggests  that  the  inhibition  by PMA  of mitogen-promoted 
Na+/H  + exchange could be due to a decrease in the protein 
kinase activity that is associated with growth factor receptors. 
Consistent with the hypothesis that phosphorylation may be 
involved in the activation of Na+/H  + exchange is the finding 
that vanadate, a  known inhibitor of phosphotyrosine phos- 
phatase in  vitro (33),  stimulates Na+/H  + exchange in  A431 
cells (30)  and  that this stimulation is inhibited  upon  PMA 
treatment (present results).  On the other hand,  PMA causes 
only a small inhibition of  the stimulation ofNa÷/H  + exchange 
that is produced upon exposure of cells  to hypertonic solu- 
tions.  This  suggests  that  the  osmotic  mechanism  for  the 
activation of the Na+/H  + antiporter bypasses certain stages in 
the pathway of the growth factor-mediated activation that are 
sensitive to PMA action. 
Phorbol esters that can block the mitogen-dependent acti- 
vation of Na+/H  + exchange can by themselves also induce a 
small elevation of pHi, apparently due to activation of Na+/ 
H +  exchange.  Phorbol  esters  that  do  not  activate  protein 
kinase  C  are  inactive  in  either  system.  The  two  effects of 
phorbol esters differ, however, in that activation of Na+/H  + 
exchange by phorbol esters requires external Ca  2+, while the 
inhibition of the mitogen-induced activation of Na+/H  + ex- 
change can take place in the absence of external Ca  2+.  The 
difference in  Ca  2+  requirements implies that the  two PMA 
effects are  mediated  at  least in  part by different pathways, 
even  though  both  may  require  interaction  of PMA  with 
protein kinase C. Since the PMA-promoted elevation of pHi 
is  small  compared to that  produced  by mitogens,  it  seems 
unlikely that the mitogen-induced elevation of phi occurs by 
a protein kinase C dependent pathway. 
The control of many metabolic pathways is often affected 
by the interplay of positive and negative effectors. The results 
presented here, together with previous observations on tyro- 
sine phosphorylation (19,  20), suggest that some of the mito- 
gen-induced  effects are  attenuated  by activation of protein 
kinase  C.  Several  reports  have  documented  activation  of 
phosphatidylinositol turnover by mitogens (15,  21-23). This 
increased turnover is likely to result in an activation of protein 
kinase C, and thereby diminish the mitogen-induced activa- 
tion of Na+/H  + exchange and possibly other mitogen-induced 
events. 
In several cells, the long-term effects of PMA and mitogens 
are synergistic rather than antagonistic.  For example, PMA 
and EGF synergistically inhibit the growth of A431  cells after 
several generations (22),  whereas  in  3T3  cells PMA  and  a 
variety of growth factors synergistically enhance cell growth 
(13). The implication of the apparent paradox, whereby PMA 
antagonizes some of the early events following mitogen ad- 
RAPID COMMUNICATIONS  1165 dition to  cells and  yet acts synergistically with  mitogens to 
affect cell growth, remains to be explored. We have recently 
shown  (unpublished  observations)  that  mitogen-induced 
changes in pHi human foreskin fibroblasts, i.e., normal cells, 
is also modulated by PMA in the same way as described here 
for A431 cells. 
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